BIOMAT Database Logo BIOMAT Database Logo

[Preliminary clinical electroencephalographic study on the treatment of epilepsy with sodium dipropylacetate (Depakine)]. 1972

R Balbi, and F Bravaccio

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Balbi, and F Bravaccio
[Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)].
September 1979, Pediatrie,
R Balbi, and F Bravaccio
[Preliminary notes on the clinical use of sodium diproplyacetate (Depakine) in infantile epilepsy].
January 1973, Rivista di neurologia,
R Balbi, and F Bravaccio
Prevention of febrile convulsions with dipropylacetate (Depakine).
November 1975, Epilepsia,
R Balbi, and F Bravaccio
[Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
April 1977, Nederlands tijdschrift voor geneeskunde,
R Balbi, and F Bravaccio
[Depakine (sodium dipropylacetate) in the treatment of epilepsies resistant to other drugs (EEG clinical study in 35 cases followed up for 3-12 months)].
January 1972, Rivista di neurologia,
R Balbi, and F Bravaccio
[Preliminary evaluation of Depakine effects in epilepsy].
January 1979, Neurologia i neurochirurgia polska,
R Balbi, and F Bravaccio
[Therapeutic results with sodium dipropylacetate in infantile myoclonus epilepsy].
January 1976, Rivista di neurologia,
R Balbi, and F Bravaccio
[Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
April 1977, Kinderarztliche Praxis,
R Balbi, and F Bravaccio
[Treatment of choreic syndromes with sodium dipropylacetate].
January 1977, Rivista di neurologia,
R Balbi, and F Bravaccio
[The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note].
July 1977, La Clinica terapeutica,
Copied contents to your clipboard!